Arcus Capital Partners LLC Has $375,000 Position in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Arcus Capital Partners LLC cut its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 2.9% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 3,994 shares of the company’s stock after selling 119 shares during the period. Arcus Capital Partners LLC’s holdings in GE HealthCare Technologies were worth $375,000 at the end of the most recent quarter.

A number of other institutional investors have also recently added to or reduced their stakes in GEHC. Pathway Financial Advisers LLC acquired a new stake in shares of GE HealthCare Technologies during the first quarter worth $25,000. LGT Financial Advisors LLC raised its position in shares of GE HealthCare Technologies by 1,673.3% in the 3rd quarter. LGT Financial Advisors LLC now owns 266 shares of the company’s stock worth $25,000 after acquiring an additional 251 shares in the last quarter. Fred Alger Management LLC acquired a new position in shares of GE HealthCare Technologies in the 2nd quarter valued at about $26,000. Capital Performance Advisors LLP acquired a new stake in GE HealthCare Technologies during the third quarter worth approximately $26,000. Finally, Ashton Thomas Securities LLC bought a new stake in GE HealthCare Technologies in the third quarter worth approximately $26,000. 82.06% of the stock is owned by institutional investors.

Analysts Set New Price Targets

A number of equities analysts have issued reports on GEHC shares. Redburn Atlantic upgraded GE HealthCare Technologies to a “strong-buy” rating in a report on Thursday, August 1st. BTIG Research upgraded shares of GE HealthCare Technologies from a “neutral” rating to a “buy” rating and set a $100.00 price target for the company in a report on Wednesday, September 18th. UBS Group downgraded shares of GE HealthCare Technologies from a “neutral” rating to a “sell” rating and decreased their price target for the company from $84.00 to $74.00 in a research note on Thursday, September 26th. Evercore ISI increased their price objective on shares of GE HealthCare Technologies from $98.00 to $102.00 and gave the stock an “outperform” rating in a research report on Tuesday, October 1st. Finally, JPMorgan Chase & Co. initiated coverage on GE HealthCare Technologies in a research report on Monday, September 9th. They issued a “neutral” rating and a $90.00 target price for the company. One investment analyst has rated the stock with a sell rating, five have given a hold rating, eight have assigned a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, GE HealthCare Technologies presently has a consensus rating of “Moderate Buy” and an average target price of $94.36.

Insider Buying and Selling at GE HealthCare Technologies

In related news, CEO Roland Rott sold 3,577 shares of GE HealthCare Technologies stock in a transaction that occurred on Wednesday, November 6th. The shares were sold at an average price of $86.48, for a total value of $309,338.96. Following the sale, the chief executive officer now owns 24,298 shares of the company’s stock, valued at approximately $2,101,291.04. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Corporate insiders own 0.27% of the company’s stock.

GE HealthCare Technologies Trading Down 0.6 %

NASDAQ:GEHC opened at $85.39 on Tuesday. The firm has a market cap of $39.01 billion, a price-to-earnings ratio of 23.46, a price-to-earnings-growth ratio of 3.08 and a beta of 1.24. The company has a debt-to-equity ratio of 1.12, a quick ratio of 0.98 and a current ratio of 1.23. The firm has a 50-day moving average price of $88.92 and a two-hundred day moving average price of $83.48. GE HealthCare Technologies Inc. has a 52 week low of $66.39 and a 52 week high of $94.55.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings data on Wednesday, October 30th. The company reported $1.14 earnings per share for the quarter, topping the consensus estimate of $1.06 by $0.08. GE HealthCare Technologies had a return on equity of 25.19% and a net margin of 8.56%. The business had revenue of $4.86 billion for the quarter, compared to analysts’ expectations of $4.87 billion. During the same quarter in the previous year, the firm earned $0.99 earnings per share. The business’s revenue was up .9% on a year-over-year basis. On average, equities analysts expect that GE HealthCare Technologies Inc. will post 4.29 earnings per share for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 15th. Shareholders of record on Friday, October 18th will be given a $0.03 dividend. This represents a $0.12 annualized dividend and a yield of 0.14%. The ex-dividend date is Friday, October 18th. GE HealthCare Technologies’s dividend payout ratio is 3.30%.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.